Paepe Dominique, Ghys Liesbeth Fe, Smets Pascale, Lefebvre Hervé P, Croubels Siska, Daminet Sylvie
Department of Small Animal Medicine and Clinical Biology, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
Department of Small Animal Medicine and Clinical Biology, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
J Feline Med Surg. 2015 Oct;17(10):880-8. doi: 10.1177/1098612X14559788. Epub 2014 Nov 25.
Diabetic kidney disease (DKD) is a frequent and serious complication in human diabetic patients, but data are limited in cats. This study was undertaken to assess whether diabetic cats are susceptible to DKD.
Kidney function was compared between 36 cats with diabetes mellitus (DM), 10 cats with chronic kidney disease (CKD) and 10 age-matched healthy cats by measuring routine kidney variables (serum creatinine [sCreat], serum urea [sUrea], urine specific gravity [USG], urinary protein:creatinine ratio [UPC]), urinary cystatin C:creatinine ratio and glomerular filtration rate (GFR). Urinary cystatin C (uCysC) was measured with a human particle-enhanced nephelometric immunoassay, validated to measure feline cystatin C, in all but two diabetic cats. GFR was evaluated by exo-iohexol clearance in 17 diabetic cats, all cats with CKD and all healthy cats.
Diabetic cats had significantly (mean ± SD) lower sCreat (123 ± 38 vs 243 ± 80 µmol/l), sUrea (11 ± 3 vs 18 ± 7 mmol/l) and urinary cystatin C:creatinine ratio (6 ± 31 vs 173 ± 242 mg/mol), and a significantly higher USG (1.033 ± 0.012 vs 1.018 ± 0.006) and GFR (2.0 ± 0.7 vs 0.8 ± 0.3 ml/min/kg) compared with cats with CKD. Compared with healthy cats, diabetic cats only had significantly lower USG (1.033 ± 0.012 vs 1.046 ± 0.008). Proteinuria (UPC >0.4) was present in 39% of diabetic cats, in 30% of cats with CKD and in none of the healthy cats. However, the UPC did not differ statistically between the three groups.
Based on evaluation of routine kidney variables, GFR and uCysC as a tubular marker at a single time point, a major impact of feline DM on kidney function could not be demonstrated.
糖尿病肾病(DKD)是人类糖尿病患者常见且严重的并发症,但猫的相关数据有限。本研究旨在评估糖尿病猫是否易患DKD。
通过测量常规肾脏指标(血清肌酐[sCreat]、血清尿素[sUrea]、尿比重[USG]、尿蛋白:肌酐比值[UPC])、尿胱抑素C:肌酐比值和肾小球滤过率(GFR),比较36只糖尿病(DM)猫、10只慢性肾病(CKD)猫和10只年龄匹配的健康猫的肾功能。除两只糖尿病猫外,其余所有糖尿病猫均采用经验证可测量猫胱抑素C的人颗粒增强散射比浊免疫分析法测量尿胱抑素C(uCysC)。对17只糖尿病猫、所有CKD猫和所有健康猫采用外源性碘海醇清除率评估GFR。
与CKD猫相比,糖尿病猫的sCreat(123±38 vs 243±80µmol/l)、sUrea(11±3 vs 18±7 mmol/l)和尿胱抑素C:肌酐比值(6±31 vs 173±242 mg/mol)显著降低,USG(1.033±0.012 vs 1.018±0.006)和GFR(2.0±0.7 vs 0.8±0.3 ml/min/kg)显著升高。与健康猫相比,糖尿病猫仅USG显著降低(1.033±0.012 vs 1.046±0.008)。39%的糖尿病猫、30%的CKD猫存在蛋白尿(UPC>0.4),而健康猫均无蛋白尿。然而,三组之间的UPC无统计学差异。
基于单次时间点对常规肾脏指标、GFR和作为肾小管标志物的uCysC的评估,未证实猫DM对肾功能有重大影响。